ClinicalTrials.Veeva

Menu

Exoskeleton Neurogenic Bowel Dysfunction Study

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status

Unknown

Conditions

Neurogenic Bowel
Spinal Cord Injuries

Treatments

Device: Exoskeleton training with Ekso NR

Study type

Interventional

Funder types

Other

Identifiers

NCT05176327
UW 21-406

Details and patient eligibility

About

The purpose of the study is to assess the effects of exoskeleton training on neurogenic bowel disorders in spinal cord injury/ disease.

Full description

After being informed about the study and the potential risks, all patients giving written consents will undergo a medical examination to ensure they are eligible and fit to proceed for the study. Subjects will be randomly assigned to intervention group and control group.

Intervention group will receive 2 consecutive courses of exoskeleton training (ET) with twelve 45-minute sessions, each to be completed in 6 to 8 weeks. The total period of training will be 12 to 16 weeks.

Control group will receive twelve 45-minute sessions of usual physiotherapy treatment (PT), consisting of maintenance exercise in the first 6 to 8 weeks, and then one course of ET with twelve 45-minute sessions in the following 6 to 8 weeks.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. SCI/D for a duration ≥ 12 months
  2. Neurological level of injury (NLI) C4 to L3 as defined in the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) 2019 revision
  3. Bowel opening via anal route or stoma
  4. Stable medical condition
  5. Stable mental condition
  6. No active painful musculoskeletal problems like fracture, infection, pressure injury, contracture or uncontrolled spasticity
  7. Age ≥ 18 years old
  8. Body height 150 - 188cm

Exclusion criteria

  1. Unstable cardiovascular or pulmonary conditions
  2. Untreated thromboembolic events
  3. Untreated psychiatric disorders
  4. History of malignancy
  5. Any contra-indications for exoskeleton training

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Intervention
Experimental group
Description:
Subjects will receive 2 consecutive courses of exoskeleton training with twelve 45-minute sessions, each to be completed in 6 to 8 weeks. The total period of training will be 12 to 16 weeks.
Treatment:
Device: Exoskeleton training with Ekso NR
Control
Active Comparator group
Description:
Subjects will receive twelve 45-minute sessions of usual physiotherapy treatment, consisting of maintenance exercise in the first 6 to 8 weeks, and then one course of exoskeleton training with twelve 45-minute sessions in the following 6 to 8 weeks.
Treatment:
Device: Exoskeleton training with Ekso NR

Trial contacts and locations

1

Loading...

Central trial contact

Chor-yin Lam, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems